Clinical Trial Update: The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for FINTEPLA (fenfluramine) as an anti-SUDEP therapy in Dravet syndrome. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Fintepla (Fenfluramine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Dravet Syndrome | Phase 4 | Status: NOT_YET_RECRUITING